OncoSec Medical Incorporated

OTCPK:ONCS.Q Stock Report

Market Cap: US$805.0k

This company listing is no longer active

This company may still be operating, however this listing is no longer active. Find out why through their latest events.

OncoSec Medical Dividends and Buybacks

Dividend criteria checks 0/6

OncoSec Medical does not have a record of paying a dividend.

Key information

n/a

Dividend yield

-432.7%

Buyback Yield

Total Shareholder Yield-432.7%
Future Dividend Yieldn/a
Dividend Growthn/a
Next dividend pay daten/a
Ex dividend daten/a
Dividend per sharen/a
Payout ration/a

Recent dividend and buyback updates

No updates

Recent updates

Seeking Alpha Oct 04

OncoSec to cut workforce by 45% as part of corporate restructuring

OncoSec Medical (NASDAQ:ONCS) on Tuesday said it would reduce its workforce by about 45% as part of a restructuring intended to focus expenses on the development of its lead clinical candidate Tavo. The company is evaluating Tavo in a phase 2b trial called KEYNOTE-695 for the treatment of metastatic melanoma, the most serious type of skin cancer. "Since joining as CEO my focus has been on reviewing all aspects of our technology and pipeline. This led to the conclusion that an operational restructuring and strategic pipeline refocus is the best course of action," ONCS top boss Robert Arch said in a statement. The company said results of the KEYNOTE-695 trial's secondary goal was expected in Q4 of this year, while results from the main goal was expected in Q1 2023. ONCS stock earlier closed -2% at $0.49.
Analysis Article Jan 28

What Type Of Shareholders Make Up OncoSec Medical Incorporated's (NASDAQ:ONCS) Share Registry?

If you want to know who really controls OncoSec Medical Incorporated ( NASDAQ:ONCS ), then you'll have to look at the...

Stability and Growth of Payments

Fetching dividends data

Stable Dividend: Insufficient data to determine if ONCS.Q's dividends per share have been stable in the past.

Growing Dividend: Insufficient data to determine if ONCS.Q's dividend payments have been increasing.


Dividend Yield vs Market

OncoSec Medical Dividend Yield vs Market
How does ONCS.Q dividend yield compare to the market?
SegmentDividend Yield
Company (ONCS.Q)n/a
Market Bottom 25% (US)1.4%
Market Top 25% (US)4.2%
Industry Average (Biotechs)2.5%
Analyst forecast (ONCS.Q) (up to 3 years)n/a

Notable Dividend: Unable to evaluate ONCS.Q's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.

High Dividend: Unable to evaluate ONCS.Q's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.


Earnings Payout to Shareholders

Earnings Coverage: Insufficient data to calculate ONCS.Q's payout ratio to determine if its dividend payments are covered by earnings.


Cash Payout to Shareholders

Cash Flow Coverage: Unable to calculate sustainability of dividends as ONCS.Q has not reported any payouts.


Discover strong dividend paying companies

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2023/06/28 01:29
End of Day Share Price 2023/06/28 00:00
Earnings2023/01/31
Annual Earnings2022/07/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

OncoSec Medical Incorporated is covered by 9 analysts. of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
James MolloyAlliance Global Partners
Thomas ShraderBTIG
Raghuram SelvarajuH.C. Wainwright & Co.